A Study to Evaluate the Efficacy and Safety of Bedaquiline (TMC207) in Participants With Multibacillary Leprosy
Clinical trial NCT03384641 · COMPLETED
Trial details
- NCT number
- NCT03384641
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-26
- Primary completion
- 2023-01-13
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.